Videos

Opexa Therapeutics, Inc. (NASDAQ: OPXA)

Neil Warma of Opexa Therapeutics joins Equities.com for another discussion to learn more about his company's personalized cellular therapies to treat multiple sclerosis (MS).based on its proprietary T-cell technology

Comments